Raymond James & Associates Rvl Pharmaceuticals PLC Transaction History

Raymond James & Associates

  • $161 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024
BUY
$0.0 - $0.19 $0 - $4,502
23,696 New
23,696 $0
Q3 2021

Nov 02, 2021
SELL
$2.79 - $4.19 $29,574 - $44,414
-10,600 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$3.26 - $4.84 $407 - $605
-125 Reduced 1.17%
10,600 $35,000
Q4 2020

Feb 12, 2021
BUY
$4.12 - $6.29 $44,187 - $67,460
10,725 New
10,725 $44,000

Others Institutions Holding RVLP

# of Institutions
1
Shares Held
92.5K
Call Options Held
0
Put Options Held
0
View Full List

About RVL Pharmaceuticals plc

RVLP Quotes by TradingView
  • Ticker RVLP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,150,000
  • Description
  • RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...
More about RVLP
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email